- Home
- FDBC vs ACIU Comparison
FDBC vs ACIU Comparison
Compare FDBC & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDBC | ACIU |
|---|---|---|
| Founded | 1902 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.8M | 213.3M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | FDBC | ACIU |
|---|---|---|
| Price | $42.50 | $3.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 7.3K | ★ 420.5K |
| Earning Date | 01-28-2026 | 03-12-2026 |
| Dividend Yield | ★ 3.94% | N/A |
| EPS Growth | ★ 68.46 | N/A |
| EPS | ★ 4.51 | N/A |
| Revenue | ★ $88,597,000.00 | $5,482,957.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $644.42 |
| P/E Ratio | $9.69 | ★ N/A |
| Revenue Growth | ★ 24.36 | N/A |
| 52 Week Low | $37.00 | $1.43 |
| 52 Week High | $50.00 | $4.00 |
Technical Indicators
Market Signals| Indicator | FDBC | ACIU |
|---|---|---|
| Relative Strength Index (RSI) | 41.48 | 53.43 |
| Support Level | $43.23 | $3.42 |
| Resistance Level | $44.12 | $3.90 |
| Average True Range (ATR) | 1.10 | 0.25 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 12.59 | 40.91 |
Price Performance
Historical ComparisonAbout FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.